Role of Corticosteroids in Reactive Arthritis
Corticosteroids should be used cautiously and sparingly in reactive arthritis, reserved primarily as short-term adjunctive therapy for severe symptoms or as intra-articular injections for localized joint inflammation, while NSAIDs remain the first-line treatment.
Treatment Algorithm for Reactive Arthritis
First-Line Therapy
- NSAIDs are the primary treatment for reactive arthritis 1
- Use at the minimum effective dose for the shortest duration possible after evaluating gastrointestinal, renal, and cardiovascular risks 2
- Combine with physiotherapy 1
When to Consider Corticosteroids
Intra-articular corticosteroid injections:
- Should be considered for localized joint inflammation when NSAIDs provide insufficient relief 2
- Particularly effective for relief of local symptoms in oligoarticular disease 1
- Can be used early in management for specific inflamed joints
Systemic corticosteroids:
- Use only occasionally and for short courses when NSAIDs fail to control symptoms 1
- Should be used at the lowest dose necessary as temporary (<6 months) adjunctive treatment 2
- Given the cumulative side effects, systemic glucocorticoids must be time-limited 2
Important Caveats
The evidence base for corticosteroids in reactive arthritis specifically is limited. The recommendations above are extrapolated from broader early arthritis and spondyloarthritis guidelines 2. Reactive arthritis typically presents as acute asymmetrical oligoarthritis following gastrointestinal or urogenital infection 1, 3, and most cases are self-limited.
Key distinction: Unlike rheumatoid arthritis where systemic corticosteroids have demonstrated efficacy in reducing structural progression 2, there is no evidence supporting this benefit in reactive arthritis. Therefore, systemic corticosteroids should be avoided as maintenance therapy.
Special Considerations
- For Chlamydia-induced reactive arthritis: Treat the underlying infection with antibiotics 1
- For chronic persistent arthritis: If symptoms persist beyond the acute phase, consider DMARDs such as sulfasalazine rather than prolonged corticosteroid use 1
- For refractory cases: TNF inhibitors may be considered before committing to long-term corticosteroid therapy 1
Monitoring Requirements
If systemic corticosteroids are used:
- Limit duration to less than 6 months 2
- Use the lowest effective dose
- Monitor for typical corticosteroid adverse effects including weight gain, hypertension, diabetes, cataracts, and osteoporosis 4
- Consider osteoporosis prophylaxis if treatment extends beyond 12 weeks 5
The fundamental principle is that corticosteroids in reactive arthritis serve as a bridge or rescue therapy, not as primary or maintenance treatment. The self-limited nature of most reactive arthritis cases and the availability of effective alternatives (NSAIDs, DMARDs for persistent disease) make prolonged corticosteroid use unjustifiable given their well-documented cumulative toxicity 2, 6.